EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more
EKF Diagnostics Holdings plc (EKDHF) - Total Assets
Latest total assets as of June 2025: $82.43 Million USD
Based on the latest financial reports, EKF Diagnostics Holdings plc (EKDHF) holds total assets worth $82.43 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
EKF Diagnostics Holdings plc - Total Assets Trend (2001–2024)
This chart illustrates how EKF Diagnostics Holdings plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
EKF Diagnostics Holdings plc - Asset Composition Analysis
Current Asset Composition (December 2024)
EKF Diagnostics Holdings plc's total assets of $82.43 Million consist of 34.9% current assets and 65.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.5% |
| Accounts Receivable | $6.28 Million | 7.7% |
| Inventory | $7.39 Million | 9.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $5.05 Million | 6.2% |
| Goodwill | $23.88 Million | 29.2% |
Asset Composition Trend (2001–2024)
This chart illustrates how EKF Diagnostics Holdings plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EKF Diagnostics Holdings plc's current assets represent 34.9% of total assets in 2024, an increase from 3.8% in 2001.
- Cash Position: Cash and equivalents constituted 17.5% of total assets in 2024, up from 0.3% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 35.0% of total assets, a decrease from 95.0% in 2001.
- Asset Diversification: The largest asset category is goodwill at 29.2% of total assets.
EKF Diagnostics Holdings plc Competitors by Total Assets
Key competitors of EKF Diagnostics Holdings plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
EKF Diagnostics Holdings plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - EKF Diagnostics Holdings plc generates 0.61x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, EKF Diagnostics Holdings plc generates $7.64 in net profit.
EKF Diagnostics Holdings plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.62 | 4.60 | 1.74 |
| Quick Ratio | 3.47 | 3.08 | 1.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $24.71 Million | $ 19.33 Million | $ 15.15 Million |
EKF Diagnostics Holdings plc - Advanced Valuation Insights
This section examines the relationship between EKF Diagnostics Holdings plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.55 |
| Latest Market Cap to Assets Ratio | 1.59 |
| Asset Growth Rate (YoY) | 1.1% |
| Total Assets | $81.75 Million |
| Market Capitalization | $129.58 Million USD |
Valuation Analysis
Above Book Valuation: The market values EKF Diagnostics Holdings plc's assets above their book value (1.59 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: EKF Diagnostics Holdings plc's assets grew by 1.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for EKF Diagnostics Holdings plc (2001–2024)
The table below shows the annual total assets of EKF Diagnostics Holdings plc from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $81.75 Million | +1.11% |
| 2023-12-31 | $80.85 Million | -9.45% |
| 2022-12-31 | $89.29 Million | -22.44% |
| 2021-12-31 | $115.12 Million | +13.68% |
| 2020-12-31 | $101.27 Million | +16.23% |
| 2019-12-31 | $87.13 Million | +7.06% |
| 2018-12-31 | $81.38 Million | +5.47% |
| 2017-12-31 | $77.16 Million | -6.40% |
| 2016-12-31 | $82.43 Million | +14.67% |
| 2015-12-31 | $71.89 Million | -47.05% |
| 2014-12-31 | $135.78 Million | +123.60% |
| 2013-12-31 | $60.72 Million | +8.98% |
| 2012-12-31 | $55.72 Million | -5.14% |
| 2011-12-31 | $58.73 Million | +63.24% |
| 2010-12-31 | $35.98 Million | +462.44% |
| 2009-12-31 | $6.40 Million | +11.48% |
| 2008-12-31 | $5.74 Million | +3.11% |
| 2007-12-31 | $5.57 Million | +7.83% |
| 2006-12-31 | $5.16 Million | +6.57% |
| 2005-12-31 | $4.84 Million | -27.25% |
| 2004-12-31 | $6.66 Million | +5.23% |
| 2003-12-31 | $6.33 Million | -1.65% |
| 2002-12-31 | $6.43 Million | +18.06% |
| 2001-12-31 | $5.45 Million | -- |